mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |